Description :
Regulus Therapeutics Inc. is a biopharmaceutical company leading the discovery of a new class of high-impact medicines based on microRNAs. MicroRNAs are small non-coding RNAs (ribonucleic acids) of 20 to 25 nucleotides in length that regulate expression of target genes through sequence specific hybridization to the 3' untranslated region (UTR) of messenger RNAs and either block translation or direct degradation of their target messenger RNAs. The discovery of microRNA in humans is one of the m
Tags :
microrna, ribonucleic acids, rna, regulus, regulus therapeutics inc., nucleotides, immune response, cell-cycle control, metabolism, viral replication, stem cell differentiation, human development, scientific breakthrough, genome, cell biology, cell functions, gene function, cellular activity, biological pathways, genetic pathways, genetics, therapeutics, disease treatment, therapeutic development, innovative chemistry, high impact medicine, microrna therapeutics, regulus therapeutics
Submitted By :
Mary French
Views :
134